Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research

Acta Histochemica

Volumn 117, Issue 4-5, 2015, Pages 329-338

  Frausin, Stefano ^a   Viventi, Serena ^a   Verga Falzacappa, Lucia ^a   Quattromani, Miriana Jlenia ^a   Leanza, Giampiero ^a   Tommasini, Alberto ^b   Valencic, Erica ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Mesenchymal stem cells; Neural differentiation; Neuroprotection; Peripheral nerve regeneration; Wharton's jelly

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; DEGENERATIVE DISEASE; GDNF GENE; HUMAN; IMMUNOMODULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PERIPHERAL NERVE INJURY; PHENOTYPE; REGENERATIVE ABILITY; REGENERATIVE MEDICINE; REVIEW; STEM CELL GENE THERAPY;

EID: 84930538866     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2015.02.005     Document Type: Review

References (93)

1. Aguilera V., Briceno L., Contreras H., Lamperti L., Sepulveda E., Diaz-Perez F., et al. Endothelium trans differentiated from Wharton's jelly mesenchymal cells promote tissue regeneration: potential role of soluble pro-angiogenic factors. PLOS ONE. 2014, 9:e111025.
2. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
3. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997, 28:1233-1244.
4. Batsali A.K., Kastrinaki M.C., Papadaki H.A., Pontikoglou C. Mesenchymal stem cells derived from Wharton's jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther 2013, 8:144-155.
5. Bigini P., Veglianese P., Andriolo G., Cova L., Grignaschi G., Caron I., et al. Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration. Rejuvenation Res 2011, 14:623-639.
6. Bobis S., Jarocha D., Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 2006, 44:215-230.
7. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006, 98:1076-1084.
8. Castro-Malaspina H., Gay R.E., Resnick G., Kapoor N., Meyers P., Chiarieri D., et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980, 56:289-301.
9. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
10. Chen M.Y., Lie P.C., Li Z.L., Wei X. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol 2009, 37:629-640.
11. Cheung W.M., Ng W.W., Kung A.W. Dimethyl sulfoxide as an inducer of differentiation in preosteoblast MC3T3-E1 cells. FEBS Lett 2006, 580:121-126.
12. Cho S.R., Kim Y.R., Kang H.S., Yim S.H., Park C.I., Min Y.H., et al. Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone barrow in a rat model of spinal cord injury. Cell Transplant 2009, 18:1359-1368.
13. Cizkova D., Rosocha J., Vanicky I., Jergova S., Cizek M. Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol 2006, 26:1167-1180.
14. Colter D.C., Sekiya I., Prockop D.J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 2001, 98:7841-7845.
15. Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999, 181:67-73.
16. Corti S., Locatelli F., Donadoni C., Guglieri M., Papadimitriou D., Strazzer S., et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004, 127:2518-2532.
17. Crigler L., Robey R.C., Asawachaicharn A., Gaupp D., Phinney D.G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006, 198:54-64.
18. Daly W., Yao L., Zeugolis D., Windebank A., Pandit A. A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery. J R Soc Interface 2012, 9:202-221.
19. Dezawa M., Takahashi I., Esaki M., Takano M., Sawada H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci 2001, 14:1771-1776.
20. Dhir S., Slatter M., Skinner R. Recent advances in the management of graft-versus-host disease. Arch Dis Child 2014, 99:1150-1157.
21. di Summa P.G., Kingham P.J., Raffoul W., Wiberg M., Terenghi G., Kalbermatten D.F. Adipose-derived stem cells enhance peripheral nerve regeneration. J Reconstr Aesthet Surg 2010, 63:1544-1552.
22. Ding F., Wu J., Yang Y., Hu W., Zhu Q., Tang X., et al. Use of tissue-engineered nerve grafts consisting of a chitosan/poly(lactic-co-glycolic acid)-based scaffold included with bone marrow mesenchymal cells for bridging 50-mm dog sciatic nerve gaps. Tissue Eng A 2010, 16:3779-3790.
23. Djouad F., Bony C., Haupl T., Uze G., Lahlou N., Louis-Plence P., et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 2005, 7:R1304-R1315.
24. Emerich D.F., Dean R.L., Bartus R.T. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Exp Neurol 2002, 173:168-181.
25. Ende N., Weinstein F., Chen R., Ende M. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci 2000, 67:53-59.
26. Fibbe W.E., Noort W.A., Mesenchymal stem cells hematopoietic stem cell transplantation. Ann N Y Acad Sci 2003, 996:235-244.
27. Freytes D.O., Kang J.W., Marcos-Campos I., Vunjak-Novakovic G. Macrophages modulate the viability and growth of human mesenchymal stem cells. J Cell Biochem 2013, 114:220-229.
28. Friedenstein A.J., Chailakhjan R.K., Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970, 3:393-403.
29. Fu Y.S., Cheng Y.C., Lin M.Y., Cheng H., Chu P.M., Chou S.C., et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 2006, 24:115-124.
30. Fu Y.S., Shih Y.T., Cheng Y.C., Min M.Y. Transformation of human umbilical mesenchymal cells into neurons in vitro. J Biomed Sci 2004, 11:652-660.
31. Gronthos S., Zannettino A.C., Hay S.J., Shi S., Graves S.E., Kortesidis A., et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003, 116:1827-1835.
32. Guan M., Xu Y., Wang W., Lin S. Differentiation into neurons of rat bone marrow-derived mesenchymal stem cells. Eur Cytokine Netw 2014, 25:58-63.
33. Hermann A., Gastl R., Liebau S., Popa M.O., Fiedler J., Boehm B.O., et al. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci 2004, 117:4411-4422.
34. Hsieh J.Y., Wang H.W., Chang S.J., Liao K.H., Lee I.H., Lin W.S., et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLOS ONE 2013, 8:e72604.
35. Hyun I., Lindvall O., Ahrlund-Richter L., Cattaneo E., Cavazzana-Calvo M., Cossu G., et al. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 2008, 3:607-609.
36. Ishii K., Katayama M., Hori K., Yodoi J., Nakanishi T. Effects of 2-mercaptoethanol on survival and differentiation of fetal mouse brain neurons cultured in vitro. Neurosci Lett 1993, 163:159-162.
37. Ishikawa N., Suzuki Y., Dezawa M., Kataoka K., Ohta M., Cho H., et al. Peripheral nerve regeneration by transplantation of BMSC-derived Schwann cells as chitosan gel sponge scaffolds. J Biomed Mater Res A 2009, 89:1118-1124.
38. Jiang G., Bi K., Tang T., Wang J., Zhang Y., Zhang W., et al. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO. Int Immunopharmacol 2006, 6:1204-1213.
39. Jones J., Jaramillo-Merchan J., Bueno C., Pastor D., Viso-Leon M., Martinez S. Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia. Neurobiol Dis 2010, 40:415-423.
40. Kaewkhaw R., Scutt A.M., Haycock J.W. Anatomical site influences the differentiation of adipose-derived stem cells for Schwann-cell phenotype and function. Glia 2011, 59:734-749.
41. Karahuseyinoglu S., Cinar O., Kilic E., Kara F., Akay G.G., Demiralp D.O., et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007, 25:319-331.
42. Karol A.G. Peripheral nerves and tendon transfers. Selected reading in plastic surgery 2003, vol. 9:23.
43. Kingham P.J., Kolar M.K., Novikova L.N., Novikov L.N., Wiberg M. Stimulating the neurotrophic and angiogenic properties of human adipose-derived stem cells enhances nerve repair. Stem Cells Dev 2014, 23:741-754.
44. Kogler G., Sensken S., Airey J.A., Trapp T., Muschen M., Feldhahn N., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004, 200:123-135.
45. Kurtz A. Mesenchymal stem cell delivery routes fate. Int J Stem Cells 2008, 1:1-7.
46. La Rocca G., Anzalone R., Corrao S., Magno F., Loria T., Lo Iacono M., et al. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 2009, 131:267-282.
47. Ladeby R., Wirenfeldt M., Garcia-Ovejero D., Fenger C., Dissing-Olesen L., Dalmau I., et al. Microglial cell population dynamics in the injured adult central nervous system. Brain Res Brain Res Rev 2005, 48:196-206.
48. Le Blanc K., Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007, 262:509-525.
49. Li J., Li D., Ju X., Shi Q., Wang D., Wei F. Umbilical cord-derived mesenchymal stem cells retain immunomodulatory and anti-oxidative activities after neural induction. Neural Regen Res 2012, 7:2663-2672.
50. Lu L.L., Liu Y.J., Yang S.G., Zhao Q.J., Wang X., Gong W., et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006, 91:1017-1026.
51. Luis A.L., Rodrigues J.M., Lobato J.V., Lopes M.A., Amado S., Veloso A.P., et al. Evaluation of two biodegradable nerve guides for the reconstruction of the rat sciatic nerve. Biomed Mater Eng 2007, 17:39-52.
52. Mafi P., Hindocha S., Dhital M., Saleh M. Advances of peripheral nerve repair techniques to improve hand function: a systematic review of literature. Open Orthop J 2012, 6:60-68.
53. Martin I.P., Ireland H., Baldomero H., Passweg J. The survey on cellular engineered tissue therapies in Europe in 2012. Tissue Eng A 2014.
54. Matsuyama T., Mackay M., Midha R. Peripheral nerve repair and grafting techniques: a review. Neurol Med Chir 2000, 40:187-199.
55. McElreavey K.D., Irvine A.I., Ennis K.T., McLean W.H. Isolation, culture and characterisation of fibroblast-like cells derived from the Wharton's jelly portion of human umbilical cord. Biochem Soc Trans 1991, 19:29S.
56. Mitchell K.E., Weiss M.L., Mitchell B.M., Martin P., Davis D., Morales L., et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 2003, 21:50-60.
57. Neuhuber B., Timothy Himes B., Shumsky J.S., Gallo G., Fischer I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005, 1035:73-85.
58. Oliveira J.T., Almeida F.M., Biancalana A., Baptista A.F., Tomaz M.A., Melo P.A., et al. Mesenchymal stem cells in a polycaprolactone conduit enhance median-nerve regeneration, prevent decrease of creatine phosphokinase levels in muscle, and improve functional recovery in mice. Neuroscience 2010, 170:1295-1303.
59. Oswald J., Boxberger S., Jorgensen B., Feldmann S., Ehninger G., Bornhauser M., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004, 22:377-384.
60. Otto W.R., Wright N.A. Mesenchymal stem cells: from experiment to clinic. Fibrog Tissue Repair 2011, 4:20.
61. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
62. Radtke C., Schmitz B., Spies M., Kocsis J.D., Vogt P.M. Peripheral glial cell differentiation from neurospheres derived from adipose mesenchymal stem cells. Int J Dev Neurosci 2009, 27:817-823.
63. Rodriguez R., Garcia-Castro J., Trigueros C., Garcia Arranz M., Menendez P. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling. Adv Exp Med Biol 2012, 741:187-205.
64. Rothwell N., Allan S., Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 1997, 100:2648-2652.
65. Saben J., Thakali K.M., Lindsey F.E., Zhong Y., Badger T.M., Andres A., et al. Distinct adipogenic differentiation phenotypes of human umbilical cord mesenchymal cells dependent on adipogenic conditions. Exp Biol Med 2014, 239:1340-1351.
66. Sanchez-Ramos J., Song S., Cardozo-Pelaez F., Hazzi C., Stedeford T., Willing A., et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000, 164:247-256.
67. Sanchez-Ramos J.R. Neural cells derived from adult bone marrow umbilical cord blood. J Neurosci Res 2002, 69:880-893.
68. Saporta S., Kim J.J., Willing A.E., Fu E.S., Davis C.D., Sanberg P.R. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res 2003, 12:271-278.
69. Scintu F., Reali C., Pillai R., Badiali M., Sanna M.A., Argiolu F., et al. Differentiation of human bone marrow stem cells into cells with a neural phenotype: diverse effects of two specific treatments. BMC Neurosci 2006, 7:14.
70. Shen L., Zeng W., Wu Y.X., Hou C.L., Chen W., Yang M.C., et al. Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells. Cell Transplant 2013, 22:1011-1021.
71. Spaggiari G.M., Capobianco A., Becchetti S., Mingari M.C., Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006, 107:1484-1490.
72. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog Neurobiol 1999, 57:563-581.
73. Subramanian A., Krishnan U.M., Sethuraman S. Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration. J Biomed Sci 2009, 16:108.
74. Suzuki M., McHugh J., Tork C., Shelley B., Hayes A., Bellantuono I., et al. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 2008, 16:2002-2010.
75. Taddio A., Biondi A., Piscianz E., Valencic E., Biagi E., Badolato R. From bone marrow transplantation to cellular therapies: possible therapeutic strategies in managing autoimmune disorders. Curr Pharm Des 2012, 18:5776-5781.
76. Tyndall A., Walker U.A., Cope A., Dazzi F., De Bari C., Fibbe W., et al. Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 2007, 9:301.
77. Uccelli A., Milanese M., Principato M.C., Morando S., Bonifacino T., Vergani L., et al. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis. Mol Med 2012, 18:794-804.
78. Uccelli A., Moretta L., Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006, 36:2566-2573.
79. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736.
80. Udina E., Rodriguez F.J., Verdu E., Espejo M., Gold B.G., Navarro X. FK506 enhances regeneration of axons across long peripheral nerve gaps repaired with collagen guides seeded with allogeneic Schwann cells. Glia 2004, 47:120-129.
81. Valencic E., Piscianz E., Andolina M., Ventura A., Tommasini A. The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation. Cytotherapy 2010, 12:154-160.
82. van Velthoven C.T., Kavelaars A., van Bel F., Heijnen C.J. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 2010, 24:387-393.
83. Wang H.S., Hung S.C., Peng S.T., Huang C.C., Wei H.M., Guo Y.J., et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004, 22:1330-1337.
84. Weiss M.L., Medicetty S., Bledsoe A.R., Rachakatla R.S., Choi M., Merchav S., et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24:781-792.
85. Wen Y., Gu W., Cui J., Yu M., Zhang Y., Tang C., et al. Platelet-rich plasma enhanced umbilical cord mesenchymal stem cells-based bone tissue regeneration. Arch Oral Biol 2014, 59:1146-1154.
86. Woodbury D., Schwarz E.J., Prockop D.J., Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000, 61:364-370.
87. Wu K.H., Zhou B., Lu S.H., Feng B., Yang S.G., Du W.T., et al. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem 2007, 100:608-616.
88. Xu W., Zhang X., Qian H., Zhu W., Sun X., Hu J., et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 2004, 229:623-631.
89. Zarbakhsh S., Moradi F., Joghataei M.T., Bahktiari M., Mansouri K., Abedinzadeh M. Evaluation of the functional recovery in sciatic nerve injury following the Co-transplantation of Schwann and bone marrow stromal stem cells in rat. Basic Clin Neurosci 2013, 4:291-298.
90. Zhang H., Huang Z., Xu Y., Zhang S. Differentiation and neurological benefit of the mesenchymal stem cells transplanted into the rat brain following intracerebral hemorrhage. Neurol Res 2006, 28:104-112.
91. Zhang H.T., Liu Z.L., Yao X.Q., Yang Z.J., Xu R.X. Neural differentiation ability of mesenchymal stromal cells from bone marrow and adipose tissue: a comparative study. Cytotherapy 2012, 14:1203-1214.
92. Zhou J., Tian G., Wang J., Luo X., Zhang S., Li J., et al. Neural cell injury microenvironment induces neural differentiation of human umbilical cord mesenchymal stem cells. Neural Regen Res 2012, 7:2689-2697.
93. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.